Skip to Content

Tindamax Approval History

FDA Approved: Yes (First approved May 17, 2004)
Brand name: Tindamax
Generic name: tinidazole
Dosage form: Tablets
Company: Presutti Laboratories
Treatment for: Trichomoniasis, Giardiasis, Bacterial Vaginitis

Tindamax (tinidazole) is a synthetic nitroimidazole antiprotozoal agent for the treatment of trichomoniasis, giardiasis, amebiasis, and bacterial vaginosis in nonpregnant women.

Development History and FDA Approval Process for Tindamax

DateArticle
May 24, 2007Approval FDA Approves Tindamax for Bacterial Vaginosis
May 17, 2004Approval Tindamax Presutti Laboratories - Treatment for Infections

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide